Ferner Rosalie E
Pract Neurol. 2010 Apr;10(2):82-93. doi: 10.1136/jnnp.2010.206532.
Neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) are inherited autosomal dominant disorders that have a significant impact on the nervous system and predispose to tumour formation. The current nomenclature makes NF1 and NF2 awkward bedfellows because they are clinically and genetically separate disorders. Neurofibromas are characteristic of NF1, a common condition with major skin involvement and many clinical complications. By contrast, schwannomas are the distinctive lesions in NF2, cutaneous signs are less prominent in this rarer disorder and clinical manifestations are largely restricted to the nervous system and eye. The current aim of neurofibromatosis specialists is to provide cohesive standards of care for everyone with neurofibromatosis and to devise standardised protocols for assessment and management within a multidisciplinary setting.
神经纤维瘤病1型(NF1)和神经纤维瘤病2型(NF2)是常染色体显性遗传病,对神经系统有重大影响,并易引发肿瘤形成。目前的命名使NF1和NF2成为关系别扭的“同路人”,因为它们在临床和遗传方面是不同的疾病。神经纤维瘤是NF1的特征性表现,这是一种常见病症,主要累及皮肤并伴有许多临床并发症。相比之下,施万细胞瘤是NF2的特征性病变,在这种较为罕见的疾病中,皮肤症状不那么突出,临床表现主要局限于神经系统和眼部。神经纤维瘤病专家目前的目标是为所有神经纤维瘤病患者提供连贯一致的护理标准,并制定多学科背景下的标准化评估和管理方案。